88 related articles for article (PubMed ID: 9446323)
1. [Genes and enzymes of the xenobiotic-metabolizing system in cancer pathology].
Liakhovich VV; Vavilin VA; Gutkina NI; Laktionova IP; Makarova SI; Mitrofanov DV; Ostashevskiĭ VA; Chasovnikova OB
Vopr Med Khim; 1997; 43(5):330-8. PubMed ID: 9446323
[TBL] [Abstract][Full Text] [Related]
2. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
Pelkonen O; Raunio H; Rautio A; Lang M
IARC Sci Publ; 1999; (148):77-88. PubMed ID: 10493250
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism of genes for xenobiotic metabolism in petrochemical workers].
Makarova OV; Viktorova TV; Ianbaeva DG; Korytina GF; Iakupova EV; Karimova LK
Genetika; 2003 Sep; 39(9):1268-74. PubMed ID: 14582397
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
[TBL] [Abstract][Full Text] [Related]
5. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
6. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
7. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
8. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
Joseph T; Chacko P; Wesley R; Jayaprakash PG; James FV; Pillai MR
Gynecol Oncol; 2006 Jun; 101(3):411-7. PubMed ID: 16360200
[TBL] [Abstract][Full Text] [Related]
9. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
10. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
11. Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study.
Quiñones LA; Irarrázabal CE; Rojas CR; Orellana CE; Acevedo C; Huidobro C; Varela NE; Cáceres DD
Asian J Androl; 2006 May; 8(3):349-55. PubMed ID: 16625286
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer].
Li WY; Lai BT; Zhan XP
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1042-5. PubMed ID: 15769360
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic NATs and cancer predisposition.
Hirvonen A
IARC Sci Publ; 1999; (148):251-70. PubMed ID: 10493262
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
16. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
[TBL] [Abstract][Full Text] [Related]
17. Influence of polymorphism at p53, CYP1A1 and GSTM1 loci on p53 mutation and association of p53 mutation with prognosis in lung cancer.
Wang YC; Chen CY; Wang HJ; Chen SK; Chang YY; Lin P
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):402-10. PubMed ID: 10418172
[TBL] [Abstract][Full Text] [Related]
18. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants.
Bufalo NE; Leite JL; Guilhen AC; Morari EC; Granja F; Assumpcao LV; Ward LS
Endocr Relat Cancer; 2006 Dec; 13(4):1185-93. PubMed ID: 17158763
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia.
D'Alò F; Voso MT; Guidi F; Massini G; Scardocci A; Sica S; Pagano L; Hohaus S; Leone G
Haematologica; 2004 Jun; 89(6):664-70. PubMed ID: 15194533
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus.
von Schmiedeberg S; Fritsche E; Rönnau AC; Specker C; Golka K; Richter-Hintz D; Schuppe HC; Lehmann P; Ruzicka T; Esser C; Abel J; Gleichmann E
Adv Exp Med Biol; 1999; 455():147-52. PubMed ID: 10599336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
